MARION MERRELL DOW INC. – Trademark Portfolio
Entity Type: 03
MARION MERRELL DOW INC. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NITRO-BID and SILVADENE. The owner is based in KANSAS CITY, MO.
9300 WARD PARKWAY
KANSAS CITY, MO
Showing of trademarks Trademarks
Trademark Classifications
MARION MERRELL DOW INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does MARION MERRELL DOW INC. have?
MARION MERRELL DOW INC. has 22 U.S. trademarks filed with the USPTO. Of these, 3 registered, 8 abandoned, 11 cancelled.
What trademark classes does MARION MERRELL DOW INC. file in?
MARION MERRELL DOW INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 16 (Paper Goods), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MARION MERRELL DOW INC.'s most well-known trademarks?
MARION MERRELL DOW INC.'s registered trademark portfolio includes well-known marks such as NITRO-BID and SILVADENE. These are among 3 currently registered trademarks in the portfolio.
What is MARION MERRELL DOW INC.'s trademark registration success rate?
MARION MERRELL DOW INC. has a 14% trademark registration rate, with 3 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.